VASOCONSTRICTOR PEPTIDES AND COLD INTOLERANCE IN PATIENTS WITH STABLE ANGINA-PECTORIS

被引:0
作者
DODDS, PA
BELLAMY, CM
MUIRHEAD, RA
PERRY, RA
机构
来源
BRITISH HEART JOURNAL | 1995年 / 73卷 / 01期
关键词
ANGINA PECTORIS; VASOCONSTRICTOR PEPTIDES; COLD INTOLERANCE;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-The exact mechanism that explains the phenomenon of cold intolerance in patients with angina remains controversial. Although the response to the effects of a cold environment has been examined in these patients, their response to cold air inhalation has produced conflicting results. In addition, the possible role of vasoactive peptides in the pathophysiology has not been explored. Objectives-The aims of this study were to examine the response of patients with stable angina to the effects of cold air inhalation during exercise testing, and to investigate the possible role played by the vasoconstrictor peptides endothelin-1 (ET-1) and angiotensin-II (AT-II) in the pathophysiology. Methods-In a randomised order, 12 men with stable angina, whose medication had been stopped, underwent two separate symptom limited treadmill exercise tests. At one visit the patients exercised while breathing room air and at the other visit they exercised while breathing cold air from a specially adapted freezer. Serial peripheral venous blood samples were taken for ET-1 and AT-II estimations during each visit. Results-Cold air inhalation resulted in a significant reduction in the mean time to angina (232.7 (20.4) a v 274.1 (26.9) s, P = 0.04) and the mean total exercise time (299.5 (27.0) s v 350.3 (23.9) s, P = 0.008), but no significant change in the time to 1 mm ST depression (223.3 (29.0) s v 241.3 (29.2) s, P = 0.25). There was no significant difference between the rate-pressure products at the onset of angina (P = 0.13) and the time to 1 mm ST depression (P = 0.85), but at peak exercise the rate-pressure product was significantly lower inpatients breathing cold air as opposed to room air (P = 0.049). There was an equivalent significant decrease in ET-1 concentrations at peak exercise compared with that at rest at both visits (room air 5.0 (0.7) pmol/l v 4.3 (0.7) pmol/l, P = 0.03; cold air 4.4 (0.6) pmol/l v 3.8 (0.5) pmol/l, P = 0.02). There was a significant increase in AT-II concentrations 10 min after peak exercise in patients breathing roam air (39.2 (6.1) pmol/l v 32.1 (4.8) pmol/l, P = 0.01) which was not repeated during cold air inhalation (36.6 (3.4) pmol/l v 28.3 (3.4) pmol/l, P = 0.07). Conclusions-Cold air inhalation in patients with stable angina results in an earlier onset of angina and a reduction in exercise capacity. Both peripheral and central reflex mechanisms appear to contribute to the phenomenon of cold intolerance. Peripheral ET-1 and AT-II do not appear to play a significant role in the pathophysiology.
引用
收藏
页码:25 / 31
页数:7
相关论文
共 50 条
  • [31] ANTIANGINAL EFFECT OF CONVENTIONAL AND CONTROLLED-RELEASE DILTIAZEM IN STABLE ANGINA-PECTORIS
    BOMAN, K
    SAETRE, H
    KARLSSON, LG
    RITTER, B
    MARSELL, R
    WINGMAN, H
    LOVHEIM, O
    MICHAELI, EW
    LOFDAHL, P
    OLSSON, SOR
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 49 (1-2) : 27 - 30
  • [32] IMPORTANCE OF CORONARY COLLATERAL CIRCULATION FOR INCREASED TREADMILL EXERCISE CAPACITY BY NITRATES IN PATIENTS WITH STABLE EFFORT ANGINA-PECTORIS
    OHNO, A
    FUJITA, M
    MIWA, K
    EJIRI, M
    ASANOI, H
    SASAYAMA, S
    CARDIOLOGY, 1991, 78 (04) : 323 - 328
  • [33] MORNING INCREASE IN HEMODYNAMIC-RESPONSE TO EXERCISE IN PATIENTS WITH ANGINA-PECTORIS
    SAITO, D
    MATSUBARA, K
    YAMANARI, H
    UCHIDA, S
    OBAYASHI, N
    MIZUO, K
    SATO, T
    KOBAYASHI, H
    MAEKAWA, K
    FUKUSHIMA, K
    HARAOKA, S
    HEART AND VESSELS, 1993, 8 (03) : 149 - 154
  • [34] ISOSORBID-5-MONONITRAT 40/60 IN PATIENTS WITH CORONARY HEART-DISEASE AND STABLE ANGINA-PECTORIS
    MAETZEL, FK
    MEDIZINISCHE WELT, 1992, 43 (01): : 82 - 89
  • [35] PREVENTION OF CARDIAC EVENTS IN PATIENTS WITH ANGINA-PECTORIS - RESULTS OF THE APSIS STUDY
    REHNQVIST, N
    HJEMDAHL, P
    BILLING, E
    BJORKANDER, I
    ERIKSSON, SV
    FORSLUND, L
    HELD, C
    NASMAN, P
    WALLEN, NH
    EUROPEAN HEART JOURNAL, 1995, 16 : 18 - 18
  • [36] ANGINA-PECTORIS AND MEDITERRANEAN SPOTTED-FEVER
    MAALOUL, I
    KANOUN, F
    BENJEMAA, M
    BENHAMED, S
    MEDECINE ET MALADIES INFECTIEUSES, 1995, 25 (8-9): : 949 - 950
  • [37] The development of heart failure in patients with stable angina pectoris
    Sutton, George C.
    Otterstad, Jan Erik
    Kirwan, Bridget-Anne
    Voko, Zoltan
    de Brouwer, Sophie
    Lubsen, Jacobus
    Poole-Wilson, Philip A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2007, 9 (03) : 234 - 242
  • [38] CIRCULATING ALPHA-ACTIN IN ANGINA-PECTORIS
    ARANEGA, AE
    REINA, A
    VELEZ, C
    ALVAREZ, L
    MELGUIZO, C
    ARANEGA, A
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1993, 25 (01) : 15 - 22
  • [39] A NEW ISOSORBIDE DINITRATE EXTENDED-RELEASE FORMULATION - PHARMACOKINETIC AND CLINICAL-PARAMETERS IN PATIENTS WITH STABLE ANGINA-PECTORIS
    KLEMSDAL, TO
    MUNDAL, HH
    RUDBERG, N
    GJESDAL, K
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 47 (04) : 351 - 354
  • [40] WHICH DRUG TO CHOOSE FOR STABLE ANGINA-PECTORIS - A COMPARATIVE-STUDY BETWEEN BISOPROLOL AND NITRATES
    VANDEVEN, LLM
    VERMEULEN, A
    TANS, JGM
    TANS, AC
    LIEM, KL
    LAGEWEG, NC
    LIE, KI
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 1995, 47 (03) : 217 - 223